thumbnail
Facilities & CapacityNovartis invests $545m to expand Austria cell culture techNovartis invests $545m to expand Austria cell culture tech
In a bid to align its manufacturing network with its strategy and technology, Novartis will invest $545 million to build two cell culture plants in Kundl and Schaftenau, Austria.